Trials / No Longer Available
No Longer AvailableNCT04878718
Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder
Vancomycin and Fecal Microbiota Transplant in a Single Patient for the Treatment of Autism Spectrum Disorder
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- —
Summary
Single patient with ASD will be treated with Vancomycin followed by FMT.
Detailed description
A single patient with profound ASD will be treated with Vancomycin. This will be followed by fecal microbiota transplant. The patient will be followed for one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbiota Transplant; Vancomycin | Subject will be treated with vancomycin followed by fecal microbiota transplant |
Timeline
- First posted
- 2021-05-07
- Last updated
- 2025-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04878718. Inclusion in this directory is not an endorsement.